348
Views
144
CrossRef citations to date
0
Altmetric
Review

New onset diabetes after transplantation (NODAT): an overview

, , , &
Pages 175-186 | Published online: 09 May 2011

References

  • Davidson J Wilkinson AH Dantal J New-onset diabetes after transplantation: 2003 International Consensus Guidelines Transplantation 2003 7 SS3 SS24 12775942
  • Wilkinson AH Davidson J Dotta F Guidelines for the treatment and management of new-onset diabetes after transplantation Clin Transplant 2005 19 291 298 15877787
  • Montori VM Basu A Erwin PJ Velosa JA Gabriel SE Kudva YC Posttransplantation diabetes: a systematic review of the literature Diabetes Care 2002 25 3 583 592 11874952
  • Baid S Cosimi AB Farrell ML Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality Transplantation 2001 72 1066 1072 11579302
  • Knobler H Stagnaro-Green A Wallenstein S Higher incidence of diabetes in liver transplant recipients with hepatitis C J Clin Gastroenterol 1998 26 30 33 9492860
  • Ye X Kuo H-T Sampaio MS Jiang Y Bunnapradest S Risk factors for the development of new-onset diabetes mellitus after transplant in adult lung transplant recipients Clin Transplant 2010 DOI 10. 1111 1 7
  • Bigam D Pennington J Carpentier A Hepatitis-C related cirrhosis: a predictor of diabetes after orthotopic liver transplantation Hepatology 2000 32 1 87 90 10869293
  • Sharif A Moore RH Baboolal K The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: an underdiagnosed phenomenon Transplantation 2006 82 12 1667 1672 17198257
  • Cosio FG Pesavento TE Osei K Henry ML Ferguson RM Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years Kidney Int 2001 59 2 732 737 11168956
  • Kasiske BL Snyder JJ Gilbertson D Maras AJ Diabetes mellitus after kidney transplantation in the United States Am J Transplant 2003 3 2 178 185 12603213
  • Sulanc E Lane JT Puumala SE Groggel GC Wrenshall LE Stevens RB New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines Transplantation 2005 80 7 945 952 16249743
  • Martinez-Castelao A Hernandez MD Pascual J Detection and treatment of post kidney transplant hyperglycemia: a Spanish multicenter cross-sectional study Transplant Proc 2005 37 9 3813 3816 16386547
  • Pham PT Danovitch GM Pham PC The medical management of the renal transplant recipient Johnson RJ Feehally John Comprehensive Clinical Nephrology 3rd ed Philadelphia, PA Mosby 2007 1085 1101
  • Hamer RA Chow CL Ong AC McKane WS Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation Transplantation 2007 83 36 40 17220788
  • Ducloux D Motte G Vautrin P Bresson-Vautrin C Rebibou JM Chalopin JM Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus Nephrol Dial Transplant 1999 14 1244 1246 10344369
  • De Mattos AM Olyaei AJ Prather JC Golconda MS Barry JM Norman DJ Autosomal dominant polycystic kidney disease as a risk factor for diabetes mellitus following transplantation Kidney Int 2005 67 714 720 15673321
  • Hjelmesaeth J Hartmann A Insulin resistance in patients with adult polycystic kidney disease Nephrol Dial Transplant 1999 14 10 2521 2522 10528694
  • Jindal RM Revanur VK Jardine AG Hakim N Stratta R Gray D Immunosuppression and Diabetogenicity 1st ed (Pancreas and islet transplantation). New York Oxford University Press 2002 247 27
  • Hjelmesaeth J Hartmann A Kofstad J Egeland T Stenstrom J Fauchald P Tapering off prenisolone and cyclosporine the first year after renal transplantation: the effect on glucose tolerance Nephrol Dial Transplant 2001 16 829 835 11274282
  • Hjelmesaeth J Hartmann A Kofstad J Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age Transplantation 1997 64 7 979 983 9381545
  • Midtvedt K Hjemesaeth J Hartmann A Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal J Am Soc Nephrol 2004 15 12 3233 3239 15579527
  • Luan FL Steffick DE Ojo AO New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression Transplantation 2011 91 3 334 341 21242885
  • Depcynski B Daly B Campbell LV Chisholm DJ Keogh A Predicting occurrence of diabetes mellitus in recipients of heart transplants Diabetes Med 2000 17 15 19
  • Woodward RS Schnitzler MA Baty J Incidence and cost of new onset diabetes mellitus among US wait-listed and transplanted renal allograft recipients Am J Transplant 2003 3 5 590 598 12752315
  • Ekberg H Tedesco-Silva H Demirbas A Reduced exposure to calcineurin inhibitors in renal transplantation N Engl J Med 2007 357 25 2562 2575 18094377
  • Vincenti F Friman S Sceuermann E Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus Am J Transplant 2007 7 6 1506 1514 17359512
  • Heisel O Heisel R Balshaw R Keown P New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis Am J Transplant 2004 4 4 583 595 15023151
  • Meiser BM Uberfuhr P Fuchs A Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection J Heart Lung Transplant 1998 17 8 782 788 9730427
  • Maes BD Kuypers D Messiaen T Posttransplant diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors Transplantation 2001 72 10 1655 1661 11726827
  • Cai TH Esterl RM Nichols F Cigarroa F Speeg KV Halff GA Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation Transplant Proc 1998 30 4 1413 1414 9636572
  • Bloom RD Rao V Weng F Grossman RA Cohen D Mange KC Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus J Am Soc Nephrol 2002 13 5 1374 1380 11961026
  • Teutonico A Schena PF Di Paolo S Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus J AM Soc Nephrol 2005 16 10 3128 3135 16107580
  • Johnston O Rose CL Webster AC Gill JS Sirolimus is associated with new-onset diabetes in kidney transplant recipients J Am Soc Nephrol 2008 19 7 1411 1418 18385422
  • Bonato V Barni R Cataldo D Analysis of posttransplant diabetes mellitus prevalence in a population of kidney transplant recipients Transplant Proc 2008 40 6 1888 1890 18675080
  • Kissebah AH Vydelingum N Murray R Relation of body fat distribution to metabolic complications of obesity J Clin Endocrinol Metab 1982 54 2 254 260 7033275
  • Eckel RH Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD Proc Nutrition Soc 2007 66 1 82 95 17343775
  • Bayer ND Cochetti PT Kumar MSA Association of metabolic syndrome with development of new-onset diabetes after transplantation Transplantation 2010 90 8 861 866 20724958
  • Kuypers DR Claes K Bammens B Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus Nephrol Dial Transplant 2008 23 6 2033 2042 18174264
  • Myslak M Amer H Morales P Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant Am J Transplant 2006 6 7 1660 1665 16827868
  • Roland M Gatault P Al-Naijjar A Early pulse pressure and low-grade proteinuria as independent long-term risk factors for new-onset diabetes after kidney transplantation Am J Transplant 2008 8 8 1719 1728 18694475
  • Pham PC Pham PM Pham SV Miller JM Pham PT Hypomagnesemia in patients with type 2 diabetes Clin J Am Soc Nephrol 2007 2 2 366 373 17699436
  • Van Laecke S Van Biesen W Verbeke F De Bacquer D Peeters P Vanholder R Postransplantation hypomagnesemia and its realtion with immunosuppression as predictors of new-onset diabetes after transplantation Am J Transplant 2009 9 9 2140 2149 19624560
  • Van Laecke S Desideri F Geerts A Hypomagenesemia and the risk of new-onset diabetes after liver transplantation Liver Transpl 2010 16 11 1278 1287 21031543
  • Cosio FG Kudva Y van der Velde M Larson TS New onset hyperglycemia and diabetes mellitus are associated with increased cardiovascular risk after kidney transplantation Kidney Int 2005 67 6 2415 2421 15882287
  • Bloom RD Lake JR Emerging issues in hepatitis C virus-positive liver and kidney transplant recipients Am J Transplant 2006 6 10 2232 2237 16869798
  • Delgado-Borrego A Casson D Schoenfeld D Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation Transplantation 2004 77 5 703 710 15021833
  • Simo R Lecube A Genesca J Esteban JI Hernandez C Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection Diabetes Care 2006 29 11 2462 2466 17065685
  • Kamar N Toupance O Buchler M Evidence that clearance of hepatitis C virus RNA after α-interferon therapy in dialysis patients is sustained after renal transplantation J Am Soc Nephrol 2003 14 8 2092 2098 12874463
  • Lehr H Jao S Waltzer WC Anaise D Rappaport FT Cytomegalovirus-induced diabetes mellitus in a renal transplant recipient Transplant Proc 1985 17 5 2152 2154 3010517
  • Hjelmesaeth J Sagedal S Hartmannn A Asymptomatic cytomegalovirus infection is associated with increased risk for new-onset diabetes and impaired insulin release after renal transplantation Diabetologia 2004 47 9 1550 1556 15338129
  • Hjelmesaeth J Muller F Jenssen T Rollag H Sagedar S Hartmann A Is there a link between cytomegalovirus infection and new-onset posttransplant diabetes mellitus? Potential mechanisms of virus induced β-cell damage Nephrol Dial Transplant 2005 20 11 2311 2315 16046502
  • Ojo AO Cardiovascular complications after renal transplantation and their prevention Transplantation 2006 82 5 603 611 16969281
  • Hjelmesaeth J Hartmann A Leivestad T The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events Kidney Int 2006 69 3 588 595 16395250
  • Boudreaux JP McHugh L Canafax DM The impact of cyclosporine and combination immunosuppression on the incidence of post transplant diabetes in renal allograft recipients Transplantation 1987 44 3 376 381 3307061
  • Kuo H-T Sampaio MS Vincenti F Associations of pretransplant diabetes mellitus, New-Onset Diabetes Mellitus after Transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database Am J Kidney Dis 2010 56 6 1026 1028 21094914
  • Pham PT Pham PC 2008 Assessing the risk of post-transplantation diabetes mellitus with an oral glucose tolerance test Nat Clin Pract Nephrol 2008 4 11 600 601 18762797
  • Mannon RB Therapeutic management of posttransplant diabetes mellitus Transplant Rev (Orlando) 2008 22 2 116 124 18631864
  • Gerstein HC Miller ME Byinhton RP for the Action to Control Cardiovascular Risk in Diabetes Study group Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 2008 358 24 2545 2559 18539917
  • Ismail-Beigi F Craven T Banerji MA for the ACCORD trial group Effect of intensive treatment of hyperglycemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomized trial Lancet 2010 376 9739 419 430 20594588
  • Scheen AJ Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomized clinical trials Diabetes Metab 2004 30 6 487 496 15671918
  • Bosch J Yusuf S Gerstein HC Effect of ramipril on the incidence of diabetes N Engl J Med 2006 355 15 1551 1562 16980380
  • Ramirez SP Albert JM Blayney MJ Rosiglitazone is associated with mortality in chronic hemodialysis patients J Am Soc Nephrol 2009 20 5 1094 1101 19357257
  • Brunelli SM Thadhani R Ikizler TA Feldman HI Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes Kidney Int 2009 75 9 961 968 19190679
  • Haidinger M Werzowa J Voigt H-C A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation Trials 2010 11 91 20925938
  • Srinivasan BT Jarvis J Khunti K Davies MJ Recent advances in the management of type 2 diabetes mellitus: a review Postgrad Med J 2008 84 996 524 531 19017837
  • Jindal RM Hjelmesaeth J Impact and management of posttransplant diabetes mellitus Transplantation 2000 70 Suppl 11 SS58 SS63 11152233
  • Hatorp V Hansen KT Thomsen MS Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics and safety of the prandial glucose regulator repaglinide J Clin Pharmacol 2003 43 6 649 660 12817528
  • Cheng AYY Fantus IG Oral antihyperglycemic therapy for type 2 diabetes mellitus CMAJ 2005 172 2 213 226 15655244
  • Niemi M Backman JT Neuvonen M Neuvonen PJ Kivisto KT Rifampin decreases the plasma concentrations and effects of repaglinide Clin Pharmacol Ther 2000 68 5 495 500 11103752
  • Froud T Faradji RN Monroy K Dapsone-induced artifactual A1C reduction in islet transplant recipients Transplantation 2007 83 6 824 825 17414719
  • Pham PT Pham PC Danovitch GM Posttransplant cardiovascular disease Semin Nephrol 2007 27 4 430 444 17616275
  • Qaseem A Humphrey L Chou R Use of intensive therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians Ann Intern Med 2011 154 4 260 267 21320941